SRR8942963
—
Clinical attributes
From the source cohort, normalized into canonical keys plus the project's native columns.
- cancer_type
- —
- cancer_type_detailed
- —
- subtype
- —
GSVA pathway preview (0 Hallmark scores)
Top 10 most elevated and top 10 most suppressed Hallmark pathways for this sample.
Patient twins — nearest pathway neighbors
10 samples closest to this one in 50-dim pathway space, drawn from the Pathway Atlas. Cosine similarity = 1 means identical pathway state.
9 twins match this tumor's tissue · 1 come from a different tissue of origin
| # | Sample | Cancer type | Subtype | cos similarity |
|---|---|---|---|---|
| 1 | TCGA-33-4587-01A-11R-2125-07 | — | cohortMD1 | 0.922 |
| 2 | TCGA-O2-A5IB-01A-11R-A27Q-07 | — | cohortMD1 | 0.920 |
| 3 | TCGA-66-2793-01A-01R-1201-07 | — | cohortMD1 | 0.914 |
| 4 | C3L-04013 | — | cohortMD1 | 0.912 |
| 5 | TCGA-E7-A5KE-01A-11R-A28M-07 | — | — | 0.911 |
| 6 | SRR3147738 | — | — | 0.908 |
| 7 | TCGA-91-6847-01A-11R-1949-07 | — | cohortMD1 | 0.904 |
| 8 | BS_M0QYNVK8 | high-grade glioma | — | 0.903 |
| 9 | ERR2208947 | — | — | 0.902 |
| 10 | TCGA-A1-A0SO-01A-22R-A084-07 | — | E | 0.901 |
Per-pathway drug coverage
For each elevated pathway in this tumor, the best-reversing drug across the catalog. Uncovered pathways = unmet need at pathway level for this one patient.
0 of 12 elevated pathways have at least one drug that meaningfully reverses them.
| Pathway (elevated) | tumor score | Best drug | reversal magnitude |
|---|---|---|---|
| E2F_TARGETS | 0.540 | Inavolisib | — uncovered |
| G2M_CHECKPOINT | 0.470 | Inavolisib | — uncovered |
| MITOTIC_SPINDLE | 0.380 | Inavolisib | — uncovered |
| MYC_TARGETS_V2 | 0.240 | Idelalisib | — uncovered |
| DNA_REPAIR | 0.190 | Idelalisib | — uncovered |
| SPERMATOGENESIS | 0.190 | Inavolisib | — uncovered |
| MYC_TARGETS_V1 | 0.160 | Inavolisib | — uncovered |
| WNT_BETA_CATENIN_SIGNALING | 0.040 | Inavolisib | — uncovered |
| ADIPOGENESIS | 0.030 | Inavolisib | — uncovered |
| PI3K_AKT_MTOR_SIGNALING | 0.030 | Inavolisib | — uncovered |
| UNFOLDED_PROTEIN_RESPONSE | 0.030 | Idelalisib | — uncovered |
| PROTEIN_SECRETION | 0.020 | Remibrutinib | — uncovered |